Latest Flu pandemic vaccine Stories
- Latest U.S.
DALLAS, August 31, 2014 /PRNewswire/ -- LifeScienceIndustryResearch.com adds "China Human Vaccine Industry Report, 2014-2017 [http://www.lifescienceindustryresearch.com/china-human-vaccine-industry-report-2014-2017.html
- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - LYON, France,
-- The Novartis influenza vaccine portfolio in the US includes Flucelvax® and Fluvirin® CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment
ChinaMarketResearchReports.com adds Latest Report on "China Animal Vaccine Industry Report, 2013-2016" to its store. DALLAS, June 27, 2014 /PRNewswire-iReach/ -- Animal vaccine is a kind of
Substantial Scientific Evidence Exists that Vaccine Ingredient is a Developmental Neurotoxin WATCHUNG, N.J., June 13, 2014 /PRNewswire-iReach/ -- Just months after U.S.
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 28, 2014 /PRNewswire/
DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n8dfqv/china_influenza) has announced the addition of the "China
bioCSL Inc. initiates 2014-15 season pre-booking for AFLURIA® (Influenza Vaccine) KING OF PRUSSIA, Pa., Feb.
- A person in a secondary role, specifically the second most important character (after the protagonist).